ORMP
Oramed Pharmaceuticals Inc
NASDAQ: ORMP · HEALTHCARE · BIOTECHNOLOGY
$3.88
+1.04% today
Updated 2026-04-30
Market cap
$163.00M
P/E ratio
2.69
P/S ratio
81.50x
EPS (TTM)
$1.50
Dividend yield
—
52W range
$2 – $4
Volume
0.1M
Oramed Pharmaceuticals Inc (ORMP) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |